Poland Non-Small Cell Lung Cancer (NSCLC) Market: Molecular Test (PCR, NGS, FISH, IHC, Others), Collection Type (Mediastinoscopy, Bronchoscopy, Needle Biopsy, Others), Cancer Type (Adenocarcinoma, Squamous Cell Carcinoma, Large Cell Carcinoma, Adenosquamous Carcinoma, Others), and Geography  

Purchase Option

$ 3100
$ 4600
$ 6900

1. Executive Summary
2. Poland Non-Small Cell Lung Cancer (NSCLC) Market Introduction
2.1. Poland Non-Small Cell Lung Cancer (NSCLC) Market – Taxonomy
2.2. Poland Non-Small Cell Lung Cancer (NSCLC) Market –Definitions
2.2.1. Molecular Test
2.2.2. Collection Type
2.2.3. Cancer Type
3. Poland Non-Small Cell Lung Cancer (NSCLC)  Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Collaborations, Acquisitions and Mergers
3.6. Poland Non-Small Cell Lung Cancer (NSCLC)  Market – Competition Landscape
3.7. Poland Non-Small Cell Lung Cancer (NSCLC)  Market Dynamic Factors - Impact Analysis
4. Poland Non-Small Cell Lung Cancer (NSCLC)  Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%)
4.3. Market Opportunity Analysis
5. Poland Non-Small Cell Lung Cancer (NSCLC)  Market, By Molecular Test Platform, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.1. PCR
5.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.1.3. Market Opportunity Analysis
5.2. NGS
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.2.3. Market Opportunity Analysis
5.3. FISH
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.3.3. Market Opportunity Analysis
5.4. IHC
5.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.4.3. Market Opportunity Analysis
5.5. Others
5.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
5.5.3. Market Opportunity Analysis
6. Poland Non-Small Cell Lung Cancer (NSCLC) Market Forecast, By Collection Type, 2017 - 2021 and Forecast, 2022 - 2028
6.1. Mediastinoscopy
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.1.3. Market Opportunity Analysis
6.2. Bronchoscopy
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.2.3. Market Opportunity Analysis
6.3. Needle Biopsy
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.3.3. Market Opportunity Analysis
6.4. Others
6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
6.4.3. Market Opportunity Analysis
7. Poland Non-Small Cell Lung Cancer (NSCLC) Market Forecast, By Cancer Type, 2017 - 2021 and Forecast, 2022 - 2028
7.1. Adenocarcinoma
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.1.3. Market Opportunity Analysis
7.2. Squamous Cell Carcinoma
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.2.3. Market Opportunity Analysis
7.3. Large Cell Carcinoma
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.3.3. Market Opportunity Analysis
7.4. Adenosquamous Carcinoma
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.4.3. Market Opportunity Analysis
7.5. Others
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Mn)
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
7.5.3. Market Opportunity Analysis
8. Research Methodology
9. Key Assumptions and Acronyms

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • Albemarle Corporation
  • Chemtura Corporation
  • Baerlocher GmbH
  • BASF
  • Clariant
  • ADEKA Corporation
  • Sumitomo Chemical Co., Ltd
  • The DOW Chemical Company
  • Akzonobel NV
  • Evonik Industries AG
  • Kaneka Corporation
  • Songwon Industrial Co., Ltd
  • Mitsui & Co., Ltd. Co., Ltd.

Adjacent Markets